Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Port-Wine Stain 1Hemangioma, Capillary 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 67Cyclophosphamide 65Gemcitabine 64toripalimab 61Paclitaxel 57Specimen Handling 55pembrolizumab 54sintilimab 53Surgical Procedures, Operative 52anlotinib 49Magnetic Resonance Spectroscopy 49Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 39camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Lasers, Solid-State × Clear all
NCT07183644 2025-09-19

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡